Stocksigma LogoStocksigma Logo

Kilitch Drugs Concludes EGM on Subsidiary Divestment and Board Appointments

Kilitch Drugs (India) Limited conducted its Extra-Ordinary General Meeting on 16th Nov'26 via video conferencing to vote on critical corporate

Kilitch Drugs Concludes EGM on Subsidiary Divestment and Board Appointments

Kilitch Drugs India Ltd 路 Extra Ordinary General Meeting 路 16 Nov 2026, 8:00 pm

Kilitch Drugs Concludes EGM on Subsidiary Divestment and Board Appointments Kilitch Drugs (India) Limited conducted its Extra-Ordinary General Meeting on 16th Nov'26 via video conferencing to vote on critical corporate restructuring proposals. Key resolutions placed before shareholders included the divestment of the company's entire shareholding in its material subsidiary and the conversion of existing debt, alongside service costs extended to the subsidiary, into equity shares. Additionally, members considered the five-year appointments of Dr. Milind Kishor Madhani and Mr. Gautam Rajan as Non-Executive Independent Directors. Final voting results and the Scrutinizer鈥檚 report will be disclosed separately.

Original exchange filing (PDF)

More announcements from Kilitch Drugs India Ltd

All Kilitch Drugs India Ltd announcements